Selinexor receives positive opinion from the EMA for the treatment of refractory myelomaAccess, Myeloma30 January 2021
Watch the webinar on ASH 2020 myeloma and AL amyloidosis highlightsAL amyloidosis, Conferences, MPE, Myeloma, Videos18 December 2020
MPE webinar on ASH 2020 myeloma and AL amyloidosis highlightsAL amyloidosis, MPE, Myeloma8 December 2020
ASH 2020 | Certain people with blood cancers and COVID-19 infection vulnerable to severe illnessAL amyloidosis, Conferences, Myeloma6 December 2020
ASH 2020 | The phase III trial Apollo supports administering daratumumab subcutaneously instead of intravenously in relapsed or refractory myeloma patientsConferences, Myeloma5 December 2020
ASH 2020 | Visit our poster on myeloma patient information needs and preferences at ASH 2020!Conferences, MPE, Myeloma5 December 2020
